Insulin Degludec (U-100) Vials and Tafenoquine Succinate (Arakoda)
Determining the interaction of Insulin Degludec (U-100) Vials and Tafenoquine Succinate (Arakoda) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Degludec (U-100) Vials-Tafenoquine Succinate (Krintafel)
- Insulin Degludec (U-100) Vials-Tafinlar
- Insulin Degludec (U-100) Vials-Tafluprost
- Insulin Degludec (U-100) Vials-Tafluprost ophthalmic
- Insulin Degludec (U-100) Vials-Tagamet
- Insulin Degludec (U-100) Vials-Tagamet HB
- Tafenoquine Succinate (Arakoda)-Insulin Degludec (U-200) Prefilled Pens
- Tafenoquine Succinate (Arakoda)-Insulin degludec and liraglutide
- Tafenoquine Succinate (Arakoda)-Insulin degludec and liraglutide Subcutaneous
- Tafenoquine Succinate (Arakoda)-Insulin degludec Subcutaneous
- Tafenoquine Succinate (Arakoda)-Insulin detemir
- Tafenoquine Succinate (Arakoda)-Insulin Detemir (Cartridges and Prefilled Syringes)